Jean Marie Naeyaert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jean Marie Naeyaert has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Katia Ongenae
Department of Dermatology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
6 shared publications J. Lambert
5 shared publicationsW. Westbroek
5 shared publications- Jo Lambert
Department of Dermatology Ghent University Hospital Ghent Belgium
4 shared publications M L Geerts
4 shared publicationsS. De Schepper
3 shared publications
Latest Publications
- 1 August 2004
- Published by Wiley in Pigment Cell Research
- Vol. 17 (4) , 441-442
In Melanocytes, RAB27B is linked to the actin cytoskeleton via exon F-Myosin va transcripts.
- 1 August 2004
- Published by Wiley in Pigment Cell Research
- Vol. 17 (4) , 441-442
In Melanocytes, RAB27B is linked to the actin cytoskeleton via exon F-Myosin va transcripts.
- 18 February 2004
- Vol. 14 (1) , 46-51
Autologous transplantation techniques for vitiligo: how to evaluate treatment outcome.
Effective methods for measuring treatment outcome in vitiligo are essential to accurately assess possible therapeutic modalities. This systematic review article aims to bring the problems concerning evaluation of treatment outcome in vitiligo studies using transplantation techniques to the attention of clinical investigators. Furthermore we highlight the interpretation of the achieved result from both physicians' and patients' view point using a questionnaire put to 558 dermatologists and 152 vitiligo patients in Belgium. There is no consensus about the choice of an evaluation method in surgical vitiligo studies. The interpretation of a 'successful' treatment result seemed to differ among dermatologists and vitiligo patients. We conclude that further research is needed to develop a universally accepted, objective, reliable and useful measurement method to evaluate the efficacy of surgical vitiligo treatments. A combination of both a clinical and a psychological measurement is likely to be the most appropriate choice.
- 18 February 2004
- Vol. 14 (1) , 46-51
Autologous transplantation techniques for vitiligo: how to evaluate treatment outcome.
Effective methods for measuring treatment outcome in vitiligo are essential to accurately assess possible therapeutic modalities. This systematic review article aims to bring the problems concerning evaluation of treatment outcome in vitiligo studies using transplantation techniques to the attention of clinical investigators. Furthermore we highlight the interpretation of the achieved result from both physicians' and patients' view point using a questionnaire put to 558 dermatologists and 152 vitiligo patients in Belgium. There is no consensus about the choice of an evaluation method in surgical vitiligo studies. The interpretation of a 'successful' treatment result seemed to differ among dermatologists and vitiligo patients. We conclude that further research is needed to develop a universally accepted, objective, reliable and useful measurement method to evaluate the efficacy of surgical vitiligo treatments. A combination of both a clinical and a psychological measurement is likely to be the most appropriate choice.
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 599-600
PP-21 New interactions of the NF1 gene product, neurofibromin, in human brain and in melanocytes
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 599-600
PP-21 New interactions of the NF1 gene product, neurofibromin, in human brain and in melanocytes
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 586
IL-28 Melanosome transport: an update
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 586
IL-28 Melanosome transport: an update
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 580
SP-12 Rab27b promotes invasion of human melanocytes through Rac/Rho signaling
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 580
SP-12 Rab27b promotes invasion of human melanocytes through Rac/Rho signaling
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 560-569
11th Meeting of the European Society for Pigment Cell Research 17-20 September 2003 Aula of Ghent University Voldersstraat 9, Gent, Belgium
- 1 October 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (5) , 560-569
11th Meeting of the European Society for Pigment Cell Research 17-20 September 2003 Aula of Ghent University Voldersstraat 9, Gent, Belgium
- Top Cited PapersOpen Access
- 5 March 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (2) , 90-100
Evidence for an Autoimmune Pathogenesis of Vitiligo
Vitiligo is a depigmenting disorder characterized by the development of white patches in various distributions, which are due to the loss of melanocytes from the epidermis. A variety of arguments from clinical observations to research findings in human and animal models support the hypothesis of autoimmunity and are reviewed in this article. The association with autoimmune diseases and organ‐specific autoantibodies is well known. Various effective treatment options have an immunosuppressive effect. Today the autoimmune pathogenesis of the disease has become a rapidly evolving field of research. Detection of circulating melanocyte antibodies in human and animal models implicates a possible role of humoral immunity. Histological and immunohistochemical studies in perilesional skin suggest the involvement of cellular immunity in vitiligo. Recently, T‐cell analyses in peripheral blood further support this hypothesis. Interestingly, new insights in the association of vitiligo and melanoma may help to clarify the role of autoimmunity in the development of vitiligo.
- 5 March 2003
- Published by Wiley in Pigment Cell Research
- Vol. 16 (2) , 90-100
Top Cited PapersOpen AccessEvidence for an Autoimmune Pathogenesis of Vitiligo
Vitiligo is a depigmenting disorder characterized by the development of white patches in various distributions, which are due to the loss of melanocytes from the epidermis. A variety of arguments from clinical observations to research findings in human and animal models support the hypothesis of autoimmunity and are reviewed in this article. The association with autoimmune diseases and organ‐specific autoantibodies is well known. Various effective treatment options have an immunosuppressive effect. Today the autoimmune pathogenesis of the disease has become a rapidly evolving field of research. Detection of circulating melanocyte antibodies in human and animal models implicates a possible role of humoral immunity. Histological and immunohistochemical studies in perilesional skin suggest the involvement of cellular immunity in vitiligo. Recently, T‐cell analyses in peripheral blood further support this hypothesis. Interestingly, new insights in the association of vitiligo and melanoma may help to clarify the role of autoimmunity in the development of vitiligo.
- 1 March 2003
- Vol. 130 (3) , 309-11
[Vitiligo: nothing new?].
- 1 March 2003
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (3) , 465-475
Interactions of Human Myosin Va Isoforms, Endogenously Expressed in Human Melanocytes, Are Tightly Regulated by the Tail Domain
- 1 March 2003
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (3) , 465-475
Interactions of Human Myosin Va Isoforms, Endogenously Expressed in Human Melanocytes, Are Tightly Regulated by the Tail Domain
- 1 January 2003
- Vol. 130, 65-8
[Xanthomas].